ARQT EPS Estimates
Arcutis Biotherapeutics, Inc.
$25.55
-$1.45(-5.37%)
46
Overall
20
Value
58
Tech
60
Quality
Market Cap
$3.23B
Volume
3.26M
52W Range
$19.30 - $34.80
Target Price
$39.13
ARQT EPS estimates: the consensus estimate for Arcutis Biotherapeutics, Inc.'s current fiscal year is $0.43 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ARQT EPS Estimates
- EPS estimate, current quarter
- $0.17
- EPS estimate, next quarter
- $0.22
- EPS estimate, current year
- $0.43
- EPS estimate, next year
- $1.06
- EPS growth, 3-year
- +71.57%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.13 |
| 2024 | $-1.16 |
| 2023 | $-3.78 |
| 2022 | $-5.66 |
| 2021 | $-4.18 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARQT | $25.55 | -5.4% | 3.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arcutis Biotherapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW